These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6999373)

  • 1. Pharmacological and metabolic interactions between ethanol and the dopamine-beta-hydroxylase inhibitor FLA 63 in mice.
    Sharkawi M
    Neuropharmacology; 1980 Mar; 19(3):277-80. PubMed ID: 6999373
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of dopamine-beta-hydroxylase inhibitors FLA-57 and FLA-63 on ethanol metabolism and aldehyde dehydrogenase activity in rats.
    Tottmar O; Hellström E; Holmberg K; Lindros KO
    Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):198-202. PubMed ID: 7136724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the dopamine-beta-hydroxylase inhibitor FLA 63 on the disposition of barbitone in the mouse.
    Sharkawi M
    J Pharm Pharmacol; 1979 May; 31(5):340-1. PubMed ID: 37309
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
    Dolphin A; Jenner P; Marsden CD
    Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of the dopamine-beta-hydroxylase inhibitor FLA 63 on the kinetics of elimination of amphetamine in the rat.
    Jonsson J; Lewander T
    J Pharm Pharmacol; 1974 Nov; 26(11):907-9. PubMed ID: 4156566
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of inhibition of dopamine beta-hydroxylase evoked by FLA-63. An in vitro study.
    Brodde OE; Nagel M; Schümann HJ
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):184-90. PubMed ID: 921409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some characteristics of amnesia induced by FLA-63 an inhibitor of dopamine beta hydroxylase.
    Botwinick CY; Quartermain D; Freedman LS; Hallock MF
    Pharmacol Biochem Behav; 1977 May; 6(5):487-91. PubMed ID: 19771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of ethanol intake following administration of dopamine-beta-hydroxylase inhibitors in rats.
    Amit Z; Levitan DE; Lindros KO
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):114-9. PubMed ID: 999391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Influence of H44/68 and FLA63 on central catecholamines and motor activity under light and darkness.
    Lemmer B; Berger T
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R13. PubMed ID: 238144
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of an inhibitor of dopamin-beta-hydroxylase on the acquistion and retention of four different avoidance tasks in mice.
    Izquierdo I; Beamish DG; Anisman H
    Psychopharmacology (Berl); 1979 May; 63(2):173-8. PubMed ID: 112636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticonvulsant action of methazolamide in mice: antagonism by various inhibitors of dopamine beta-hydroxylase.
    Lotti VJ; Torchiana ML; Stone CA
    Eur J Pharmacol; 1977 Aug; 44(4):387-90. PubMed ID: 19268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of some dopamine-beta-hydroxylase inhibitors on the control mechanisms of the estrous cycle in rats.
    Kun I
    Endocrinologie; 1978; 16(4):263-8. PubMed ID: 569899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-aggressive action of dopamine-beta-hydroxylase inhibitors in mice.
    Ross SB; Ogren SO
    J Pharm Pharmacol; 1976 Jul; 28(7):590-2. PubMed ID: 8618
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of two inhibitors of dopamine beta-hydroxylase on maturation of memory in mice.
    Flexner JB; Flexner LB
    Pharmacol Biochem Behav; 1976 Aug; 5(2):117-21. PubMed ID: 996046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The irritant properties of dopamine-beta-hydroxylase inhibitors in relation to their effects on L-dopa-induced locomotor activity.
    Dolphin A; Elliott PN; Jenner P
    J Pharm Pharmacol; 1976 Oct; 28(10):782-5. PubMed ID: 10378
    [No Abstract]   [Full Text] [Related]  

  • 16. Interference of inhibitors of dopamine-beta-hydroxylase with uptake of monoamines by chromaffin granular membranes.
    Schlichter D; Da Prada M; Pletscher A
    Eur J Pharmacol; 1975 Nov; 34(1):223-7. PubMed ID: 187432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

  • 18. On the mechanism of amphetamine-induced behavioural changes in the mouse. III. Effects of apomorphine and Fla 63.
    Thomas KV; Handley SL
    Arzneimittelforschung; 1978; 28(6):993-7. PubMed ID: 582011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carbon disulfide and FLA-63 on operant behavior in pigeons.
    Levine TE
    J Pharmacol Exp Ther; 1976 Dec; 199(3):669-78. PubMed ID: 994023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine-beta-hydroxylase inhibitors modulate the concentration of functional estrogen receptors in female rat hypothalamus and pituitary gland.
    Blaustein JD; Brown TJ; Swearengen ES
    Neuroendocrinology; 1986; 43(2):150-8. PubMed ID: 3014364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.